Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 185-193, 1 December 2006

A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria

  • Hristina Jovanovic

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
  • ,
  • Åsta Cerin

      Affiliations

    • Karolinska Institutet, Department of Woman and Child Health, Stockholm, Sweden
  • ,
  • Per Karlsson

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
  • ,
  • Johan Lundberg

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
  • ,
  • Christer Halldin

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
  • ,
  • Anna-Lena Nordström

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Department of Clinical Neuroscience, Psychiatry Section, Karolinska Psychiatric Center, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Tel.: +46 8 517 744 65; fax: +46 8 517 717 53.

Received 24 January 2006; received in revised form 19 April 2006; accepted 5 May 2006.

Abstract 

The cause of premenstrual dysphoric disorder (PMDD) is largely unknown. It has been hypothesized that normal ovarian function triggers PMDD-related biochemical events within the brain and that serotonin plays an important role. In the present study, positron emission tomography (PET) and [carbonyl-11C]WAY-100635 were used to examine serotonin 5-HT1A receptors in a control group of women and in a group of women with PMDD. Two PET examinations were performed in each subject, one before (follicular phase) and one after ovulation (luteal phase). Each subject's menstrual cycle was confirmed by ultrasonography of the ovaries as well as with hormone levels in blood and urine. The 5-HT1A binding potential was measured in six regions of interest and calculated according to the simplified reference tissue model. In the raphe nuclei, the 5-HT1A binding potential changed from the follicular to the luteal phase of the menstrual cycle in asymptomatic controls. In women with PMDD, the observed change between phases was significantly smaller. The results are in concordance with previously reported challenge studies of 5-HT1A receptor-mediated effects indicating different serotonergic responses between women with PMDD and controls. The study principally provides new support, in vivo, for a serotonergic dysregulation in women with PMDD.

Keywords: PMDD, Serotonin, 5HT1A, Positron emission tomography, Gonadal hormones

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0925-4927(06)00090-4

doi:10.1016/j.pscychresns.2006.05.002

Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 185-193, 1 December 2006